# Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System

> **NCT00068666** · PHASE2 · TERMINATED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 41 (actual)

## Conditions studied

- Melanoma (Skin)
- Metastatic Cancer

## Interventions

- **DRUG:** temozolomide
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00068666
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-01
- **Primary completion:** 2005-03
- **Final completion:** 2010-03
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2016-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00068666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00068666, "Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00068666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*